Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2024 Earnings Call Transcript February 26, 2025
Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.69.
Operator: Good day, and welcome to Rhythm Pharmaceuticals Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to David Connolly, IR and Corporate Communications.
David...
